Introduction
Human trials and animal experiments have demonstrated that the replication-defective adenovirus vector has high potential for use in gene therapy. Adenovirus vectors can be produced inexpensively at high titers and are highly effective at transferring exogenous genes to both replicating and nonreplicating cells. Following infection, the transferred adenovirus genome remains epichromosomal, resulting in no risk of insertional mutagenesis. However, the use of adenovirus vectors in gene therapy has been limited by immune responses in the target organ, causing transient gene expression and the inability to readminister the adenovirus. 1, 2 It has been demonstrated that the immune responses to adenovirus vectors are biphasic in nature. [3] [4] [5] [6] [7] [8] An early nonspecific acute inflammatory response occurs over the first 4 days following adenovirus administration. A late specific acquired immune response begins 5-7 days postinfection and lasts for several weeks. Until recently, research focused on the late phase, which is directed against viral antigens and is characterized by antibody formation and the infiltration of cytotoxic T lymphocytes. 9, 10 The early phase is now believed to be the most important determinant of the efficiency of in vivo gene transfer and expression. 11 Studies have shown that acute inflammation is responsible for the loss of 70-90% of the transferred genes 12 and is directly linked to early tissue injury. 13 Perhaps the most convincing evidence of the importance of controlling this acute inflammation is the disturbing result of the 1999 clinical trial where acute inflammation resulted in the death of one volunteer receiving liver-directed gene therapy. 14, 15 The acute inflammation elicited by adenovirus vectors is characterized by early neutrophil infiltration, followed by monocyte and macrophage accumulation. In the lung, neutrophil accumulation was found as early as 6 h following administration 11 and peaked 2 days after injection 5, 6, 16 with mononuclear infiltrates on the third day. 11 Neutrophil accumulation in salivary glands was most evident 1-2 days after infection with predominantly mononuclear infiltrates on the third day. 7 In the liver, significant infiltrates of neutrophils, monocytes, macrophages, and natural killer cells are visible as early as 1 h following infection. 13 The acute inflammatory response is due to direct toxicity of the virus, is multiplicity-of-infection dependent, and is present in immunodeficient animals. 6, 7, 11, 12 This inflammation also appears to be unrelated to virus-based gene expression, 7 is independent of the adenoviral backbone, 17 and is independent of both the type of expression cassette and particle-to-PFU ratio of the vector preparation. 12 Whether this acute inflammation is dose-dependent is controversial. 12, 13 Heme oxygenase (HO) is the rate-limiting enzyme in the degradation of heme to carbon monoxide (a vasodilator), iron which is converted into ferritin (an antioxidant), and biliverdin which is subsequently converted into bilirubin (an antioxidant). 18, 19 There are three known isozymes of HO. Heme oxygenase-1 (HO-1) is the inducible form of HO and is constitutively expressed in liver and spleen. HO-1 is a heat shock protein (HSP32) and is highly inducible by a variety of stimuli, such as heat shock, ischemia, radiation, hypoxia, hyperoxia, inflammation, and disease states. In addition, HO has been shown to provide protection to a variety of tissues (including heart, lung, liver, brain, and kidney) following stress. Adenovirus-mediated gene transfer of HO-1 has been successfully demonstrated both in vitro and in vivo. Gene transfer of HO-1 protected retinal pigment cells from hemoglobin toxicity and hemorrhage 20 and protected ocular tissues against oxidative stress. 21 Gene transfer of HO-1 was used as a pretreatment to protect against hyperoxia-induced lung injury 22 and to protect liver from ischemia/reperfusion injury. 23 In these studies, adenovirus-mediated overexpression of the HO-1 gene yielded effects consistent with pharmacologic upregulation of HO-1. Specifically, overexpression of HO-1 provided protection against inflammationand oxidant-mediated injury. We therefore hypothesize that the adenovirus vector containing the gene construct for HO-1 (Ad-HO-1) does not result in the acute inflammation normally induced by adenovirus vector administration. We further hypothesize that Ad-HO-1 can prevent the acute inflammation caused by a second adenovirus, resulting in a new approach to gene therapy.
Results
To evaluate the level of the acute inflammatory response elicited by the adenovirus encoding the gene for HO-1 (Ad-HO-1), mice were administered the virus by intraperitoneal injection. Intraperitoneal injection of adenovirus has been shown to be an effective noninvasive method of administration to specifically target the murine liver. 24, 25 The dose of 10 9 PFU is commonly utilized and has been shown to initiate significant inflammatory and immune responses. 7, 17, [26] [27] [28] Following 24 or 72 h, the level of hepatic inflammation was quantified using intravital video microscopy and histopathological analysis. This was compared to mice receiving injection of either the vehicle or a control vector containing the gene for b-galactosidase (Ad-bGal). A fourth experimental group received injection of Ad-HO-1 and Ad-b-Gal simultaneously in order to evaluate the effect of Ad-HO-1 on Ad-b-Gal-induced inflammation. Generally, animals from all experimental groups showed occasional hepatocyte necrosis and a small number of minute foci of inflammation, consisting predominantly of monocytes. This is consistent with previous studies that demonstrate that severe viral-hepatitis-like changes do not occur until the late phase of adenovirus-induced inflammation. 10, 26 Serum levels of alanine transaminase (ALT) were increased twofold (Po0.05) 24 h following injection of Ad-b-Gal compared with both vehicle and Ad-HO-1 administration, indicating hepatocellular injury (Ad-b-Gal¼3176 U/l; Ad-HO-1¼1572 U/l; vehicle¼1471 U/l). This increase in ALT was prevented by simultaneous administration of Ad-HO-1 (Ad-HO1+Ad-b-Gal¼1672 U/l). There was no increase in ALT measured at 72 h following administration of Ad-b-Gal.
Intravital video microscopy was used to acquire a quantitative in vivo measure of activated intravascular leukocytes. Leukocytes that were rolling or adhering in postsinusoidal venules were counted over a 1-min observation period (Figure 3 ). The total number (rolling+adherent) of leukocytes was significantly elevated 
Discussion
Adenovirus vectors hold significant promise for advancing human gene therapy. However, understanding and controlling the immune and inflammatory responses to adenovirus vectors is essential for their effective use in clinical applications. In spite of recent interest, the mechanisms of adenovirus vector-induced acute inflammation remain to be fully elucidated. Acute inflammation is known to be caused both by the transduction of foreign proteins and by the viral capsid. Several studies have demonstrated upregulation of proinflammatory genes and adhesion molecule expression by adenovirus vectors. The C-C chemokine RANTES, interferon-inducible protein-10 (IP-10), 29, 30 interleukin-6 (IL-6), 8, 31, 32 interleukin-8 (IL-8), 16, 33 interleukin-12 (IL-12), 31 tumor necrosis factor-a (TNF-a), 8, 31, 32 and nuclear factor-kB (NF-kB) 8 are induced by adenovirus vectors. 13 Intercellular adhesion molecule-1 (ICAM-1), 34, 35 vascular cell adhesion molecule-1 (VCAM-1), 35 and adhesion molecule CD34 35 are upregulated following adenovirus vector administration. 34, 35 Although the mechanisms of adenovirus-induced acute inflammation require further study, the efficiency of adenovirus administration is known to be greatly improved by adjunct treatment with antiinflammatory agents. 11 This tactic, however, may be inappropriate for clinical applications since immune depletion poses additional risks to the patient.
Carbon monoxide (a vasodilator), ferritin (an antioxidant), and bilirubin (an antioxidant) are produced by HO-mediated degradation of heme. 18, 19 Although HO-1 is a known anti-inflammatory, the mechanisms of its antiinflammatory action have not been completely elucidated. HO activity is known to downregulate ICAM-1 36, 37 and inhibit TNF-a-induced apoptosis. 38, 39 In addition, carbon monoxide is a potent vasodilator, 18 can inhibit platelet aggregation, 40 and has been shown to inhibit the proinflammatory cytokines TNF-a, interleukin-1b (IL-1b), and macrophage inflammatory protein-1b (MIP-1b). 41 Bilirubin has been shown to decrease expression of P-selectin 36, 42 and E-selectin. 42 In spite of early explorations of adenovirus-mediated gene transfer of HO-1, which have demonstrated anti-inflammatory effects consistent with pharmacologic upregulation of HO-1, this is the first study to explore the potential of reducing adenovirus vector-induced acute inflammation using Ad-HO-1. 
HO-1 prevents adenovirus-induced inflammation SD McCarter et al
This study confirmed that Ad-HO-1 does not itself elicit an acute inflammatory response in the liver within 3 days of administration. The control virus Ad-b-Gal, however, induced approximately a three-fold increase in the number of intravascular leukocytes exhibiting inflammatory behavior and induced approximately a twofold increase in leukocytes and macrophages. When Ad-HO-1 and Ad-b-Gal were administered concurrently, no inflammation was observed either by intravital video microscopy or by histopathological analysis. These data demonstrate that coadministration of Ad-HO-1 prevents the acute inflammation normally caused by Ad-b-Gal. Future studies will focus on the mechanisms involved in the prevention of adenovirus vector-induced acute inflammation by coadministration of Ad-HO-1 and will explore the effect of coadministration of Ad-HO-1 on late-phase immune responses to adenovirus vectors. These results have a profound implication for gene therapy, since the acute inflammation elicited by an adenovirus vector encoding a therapeutic gene can be prevented by coadministration of Ad-HO-1. The prevention of acute inflammation will greatly improve the safety and efficiency of adenovirus vector administration, providing strong incentive to reconsider the use of adenovirus vectors for human gene therapy.
Methods

Adenovirus vectors
The recombinant E1-deleted adenovirus containing rat HO-1 cDNA has been described previously. 22 Briefly, a 1.0 kbp XhoI-HindIII fragment from the rat HO-1 cDNA clone pRHO-1, 43 containing the entire coding region, was cloned into plasmid pAC-CMVpLpA. 44 Recombinant HO-1 adenovirus Ad-HO-1 was generated by homologous recombination in 293 N3S cells after cotransfection with the pAC-HO-1 recombinant plasmid. The recombinant E1-deleted adenovirus containing the Escherichia coli b-galactosidase gene, Ad-b-Gal, has been described. 45 Briefly, the b-galactosidase gene was cloned into the BcgIII restriction site of the adenovirus shuttle plasmid pAdCMVlink. 46 Recombinant b-galactosidase adenovirus Ad-b-Gal was generated by homologous recombination in 293 cells after cotransfection with replication-defective sub-360 viral DNA.
Animals
Male C57BL6 mice (weighing 23-27 g) were randomly assigned to groups receiving an intraperitoneal injection of (i) 100 ml of the vehicle (10 mM Tris pH 8.0, 2 mM MgCl 2 , 4% sucrose; n¼17), (ii) 100 ml of vehicle containing 10 9 PFU of Ad-HO-1 (n¼20), (iii) 100 ml of vehicle containing 10 9 PFU of Ad-b-Gal (n¼24), or (iv) 100 ml of vehicle containing 10 9 PFU of Ad-HO-1 and 10 9 PFU of Ad-b-Gal (n¼16). Intraperitoneal injection of adenovirus has been shown to be an effective noninvasive method of administration to target the murine liver. 24, 25 Specific immune responses, characterized by lymphocyte infiltration, have been reported as early as 4 days following adenovirus administration. 4, 5 Therefore, in order to ensure that observations reflect only acute inflammatory responses, the measurement times were chosen to be within 3 days following infection. Mice were therefore further randomized into different time points: 24, 48 (data not shown), or 72 h. At the designated time, animals underwent intravital video microscopy following which the right lateral hepatic lobe was removed and fixed in 10% buffered formalin and the remaining liver was immediately frozen and stored at À801C.
Reverse transcription-polymerase chain reaction
Total tissue RNA was extracted by using Trizol reagent (Life Technologies, Rockville, USA), according to the manufacturer's instructions. Primers used for rat HO-1 were sense CTGCTAGCCTGGTTCAAGATA and antisense CATCTCCTTCCATTCCAGAG. Primers used for b-galactosidase were sense GACGTCTCGTTGCTGCA TAA and antisense CAGCAGCAGACCATTTTCAA. Primers used for rat glyceraldehyde-3-phosphophate dehydrogenase (GAPDH) were sense TCCCTCAA GATTGTCAGCAA and antisense AGATCCACAACG GATACATT. The size of the HO-1 product is 316 bp, bGalactosidase product is 399 bp, and GAPDH product is 309 bp. A reaction mixture (50 ml) was made according to Access RT-PCR System (Promega, Madison, USA), which consisted of 0.8 mg RNA, 10 ml AMV/Tfl 5 Â reaction buffer, 1 ml dNTP mix (10 mM each dNTP), 50 pmol sense primer, 50 pmol antisense primer, 2 ml 25 mM MgSO 4 , 1 ml AMV reverse transcriptase (5 U/ml), and 1 ml Tfl DNA polymerase (5 U/ml). Nuclease-free mineral oil (20 ml) was overlaid on the reaction mixture. Conditions for HO-1 and GAPDH RT-PCR were: one cycle at 481C for 45 min; one cycle at 951C for 2 min; 30 cycles at 951C for 30 s, 601C for 1 min, and 681C for 90 s; and one cycle at 681C for 5 min. Conditions for b-galactosidase were: one cycle at 481C for 45 min; one cycle at 951C for 2 min; 36 cycles at 941C for 30 s, 601C for 1 min, and 681C for 1 min; and one cycle at 681C for 7 min. Each reaction product (10 ml) was then separated on a 1% agarose gel containing 0.5 mg/ml of ethidium bromide. To determine the relative intensity of mRNA bands, they were quantified using an imaging densitometer (BioRad Laboratories, Canada) and expressed as the ratio of HO-1 or b-galactosidase mRNA to GAPDH mRNA.
Heme oxygenase activity
HO activity was measured in the liver microsomes as described previously. 47 Briefly, microsomes were prepared from harvested tissues and added to a reaction mixture containing potassium phosphate buffer (0.1 M potassium phosphate-buffered saline (KPBS), pH 7.4), hemin (25 mM, Porphrin Products Inc., USA), and mouse liver cytosol (as a source of biliverdin reductase, prepared from 105 000 g supernatant). The reaction was initiated with the addition of NADPH (0.4 mM). The reaction was conducted in duplicate, in the dark, in a shaker water bath at 371C for 30 min. Placing the samples on ice terminated the reaction. Bilirubin concentration was calculated by the difference in absorbance at 470 and 530 nm, using an extinction coefficient of 40 mM À1 cm
À2
. HO activity was expressed as micromoles of bilirubin produced per hour per milligram protein, as determined by Bradford assay. 48 
Histological analysis
Formalin-fixed liver tissue was embedded in paraffin, and 5 mm thick sections were stained with hematoxylin and eosin for histopathological examination. Histopathological analysis of liver sections was performed in a HO-1 prevents adenovirus-induced inflammation SD McCarter et al blinded fashion by an experienced hepatopathologist. Cytopathic effects and inflammatory cell infiltration (specifically, cell ballooning, tissue necrosis, compromised lobular structure, and the presence of minute to large foci of inflammation) were noted. Additionally, randomly selected fields from each liver section were examined and the number of leukocytes (intravascular and extravasated) and macrophages per field of view was counted.
Immunohistochemistry
Standard immunohistochemical techniques were used for detection of HO-1. Briefly, serial sections were initially rehydrated and stained with hematoxylin. Endogenous peroxidase activity was inhibited using 3% H 2 O 2 in methanol for 5 min. Following 10% horse serum blocking, sections were incubated with 1:100 rabbit anti-HO-1 polyclonal antibody (Stressgen, Victoria, Canada) for 1.5 h. Following primary incubation, tissue sections were stained for antigen-antibody complexes using a peroxidase detection system (Vectastain ABC kit, Vector Laboratories Inc., Burlingame, USA).
Intravital video microscopy
Intravital video microscopy is an established method for evaluating inflammation 49, 50 and provides a unique tool for evaluating the local tissue inflammation resulting from adenovirus administration. Mice were anaesthetized by inhalation of isoflurane (5% induction, 2.5% laparotomy, 2% maintenance) with a mixture of nitrogen (2.5 l/min) and oxygen (1 l/min). A transverse incision was made across the midline just below the xiphoid. The left hepatic lobe was exposed and reflected onto the stage of an inverted microscope (Nikon Eclipse TE300) with a few drops of warmed saline. The liver was covered with plastic film in order to prevent dehydration and minimize movement due to respiration. Throughout microscopy, body temperature was maintained between 36.0 and 37.01C. The liver was illuminated using a fibreoptic light guide and video images were recorded for later analysis. Sufficient magnification was used for easy identification of intravascular leukocytes. Seven fields of view containing a postsinusoidal venule and 10 fields of view containing only sinusoids were recorded each for a 1-min observation period. For each venule, the number of leukocytes either rolling or stationery (ie exhibiting inflammatory behavior) over the observation period was counted. These numbers were normalized to the venular area in the field of view and expressed as the number of leukocytes (rolling+stationery) per 100 mm 2 of venule per minute. For each sinusoidal field of view, the number of leukocytes that remained stationery over the observation period was counted and expressed as the number per field of view.
Alanine transaminase
Prior to euthanasia, a blood sample was obtained by cardiac puncture. Serum levels of ALT, as an index of hepatocellular injury, were determined by standard enzymatic techniques.
Statistics
Data are expressed as the mean 7 the standard error of the mean (s.e.m.). To compare the differences in the mean values among multiple groups, a standard one-way ANOVA followed by post hoc comparison using the Student-Newman-Keuls test was used. A P-value of o0.05 was considered significant.
